Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.

Drug Des Devel Ther · 2013 · PMC3782406 · PMID 24068868

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Unlike patients treated with GLP-1 agonists (in particular liraglutide), the reported event rate for thyroid cancer did not reach statistical significance in sitagliptin-treated patients.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.